Table of Content

1 Report Overview
1.1 Pediatric Vaccines Definition
1.2 Market by Type
1.2.1 Global Pediatric Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Others
1.3 Market Segment by Application
1.3.1 Global Pediatric Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.3.5 Dolescent
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Pediatric Vaccines Sales
2.1 Global Pediatric Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Pediatric Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Pediatric Vaccines Revenue by Region
2.3.1 Global Pediatric Vaccines Revenue by Region (2018-2024)
2.3.2 Global Pediatric Vaccines Revenue by Region (2024-2034)
2.4 Global Pediatric Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Pediatric Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Pediatric Vaccines Sales Quantity by Region
2.6.1 Global Pediatric Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Pediatric Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Pediatric Vaccines Sales Quantity by Manufacturers
3.1.1 Global Pediatric Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Pediatric Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Pediatric Vaccines Sales in 2022
3.2 Global Pediatric Vaccines Revenue by Manufacturers
3.2.1 Global Pediatric Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Pediatric Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pediatric Vaccines Revenue in 2022
3.3 Global Pediatric Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Pediatric Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pediatric Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pediatric Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Pediatric Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Pediatric Vaccines Sales Quantity by Type
4.1.1 Global Pediatric Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Pediatric Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Pediatric Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Pediatric Vaccines Revenue by Type
4.2.1 Global Pediatric Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Pediatric Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Pediatric Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Pediatric Vaccines Price by Type
4.3.1 Global Pediatric Vaccines Price by Type (2018-2024)
4.3.2 Global Pediatric Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Pediatric Vaccines Sales Quantity by Application
5.1.1 Global Pediatric Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Pediatric Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Pediatric Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Pediatric Vaccines Revenue by Application
5.2.1 Global Pediatric Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Pediatric Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Pediatric Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Pediatric Vaccines Price by Application
5.3.1 Global Pediatric Vaccines Price by Application (2018-2024)
5.3.2 Global Pediatric Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Pediatric Vaccines Sales by Company
6.1.1 North America Pediatric Vaccines Revenue by Company (2018-2024)
6.1.2 North America Pediatric Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Pediatric Vaccines Market Size by Type
6.2.1 North America Pediatric Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Pediatric Vaccines Revenue by Type (2018-2034)
6.3 North America Pediatric Vaccines Market Size by Application
6.3.1 North America Pediatric Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Pediatric Vaccines Revenue by Application (2018-2034)
6.4 North America Pediatric Vaccines Market Size by Country
6.4.1 North America Pediatric Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Pediatric Vaccines Revenue by Country (2018-2034)
6.4.3 North America Pediatric Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pediatric Vaccines Sales by Company
7.1.1 Europe Pediatric Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Pediatric Vaccines Revenue by Company (2018-2024)
7.2 Europe Pediatric Vaccines Market Size by Type
7.2.1 Europe Pediatric Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Pediatric Vaccines Revenue by Type (2018-2034)
7.3 Europe Pediatric Vaccines Market Size by Application
7.3.1 Europe Pediatric Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Pediatric Vaccines Revenue by Application (2018-2034)
7.4 Europe Pediatric Vaccines Market Size by Country
7.4.1 Europe Pediatric Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Pediatric Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Pediatric Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Pediatric Vaccines Sales by Company
8.1.1 China Pediatric Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Pediatric Vaccines Revenue by Company (2018-2024)
8.2 China Pediatric Vaccines Market Size by Type
8.2.1 China Pediatric Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Pediatric Vaccines Revenue by Type (2018-2034)
8.3 China Pediatric Vaccines Market Size by Application
8.3.1 China Pediatric Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Pediatric Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Pediatric Vaccines Sales by Company
9.1.1 APAC Pediatric Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Pediatric Vaccines Revenue by Company (2018-2024)
9.2 APAC Pediatric Vaccines Market Size by Type
9.2.1 APAC Pediatric Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Pediatric Vaccines Revenue by Type (2018-2034)
9.3 APAC Pediatric Vaccines Market Size by Application
9.3.1 APAC Pediatric Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Pediatric Vaccines Revenue by Application (2018-2034)
9.4 APAC Pediatric Vaccines Market Size by Region
9.4.1 APAC Pediatric Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Pediatric Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Pediatric Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pediatric Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Pediatric Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Pediatric Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Pediatric Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Pediatric Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Pediatric Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Pediatric Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Pediatric Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Pediatric Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 GlaxoSmithKline Pediatric Vaccines Products and Services
11.1.5 GlaxoSmithKline Pediatric Vaccines SWOT Analysis
11.1.6 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Merck Pediatric Vaccines Products and Services
11.2.5 Merck Pediatric Vaccines SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Pfizer Pediatric Vaccines Products and Services
11.3.5 Pfizer Pediatric Vaccines SWOT Analysis
11.3.6 Pfizer Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Sanofi Pediatric Vaccines Products and Services
11.4.5 Sanofi Pediatric Vaccines SWOT Analysis
11.4.6 Sanofi Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 AstraZeneca Pediatric Vaccines Products and Services
11.5.5 AstraZeneca Pediatric Vaccines SWOT Analysis
11.5.6 AstraZeneca Recent Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Overview
11.6.3 Novartis Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Novartis Pediatric Vaccines Products and Services
11.6.5 Novartis Pediatric Vaccines SWOT Analysis
11.6.6 Novartis Recent Developments
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Information
11.7.2 Takeda Pharmaceutical Overview
11.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Takeda Pharmaceutical Pediatric Vaccines Products and Services
11.7.5 Takeda Pharmaceutical Pediatric Vaccines SWOT Analysis
11.7.6 Takeda Pharmaceutical Recent Developments
11.8 Bavarian Nordic
11.8.1 Bavarian Nordic Company Information
11.8.2 Bavarian Nordic Overview
11.8.3 Bavarian Nordic Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Bavarian Nordic Pediatric Vaccines Products and Services
11.8.5 Bavarian Nordic Pediatric Vaccines SWOT Analysis
11.8.6 Bavarian Nordic Recent Developments
11.9 Baxter
11.9.1 Baxter Company Information
11.9.2 Baxter Overview
11.9.3 Baxter Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Baxter Pediatric Vaccines Products and Services
11.9.5 Baxter Pediatric Vaccines SWOT Analysis
11.9.6 Baxter Recent Developments
11.10 LG Life Sciences
11.10.1 LG Life Sciences Company Information
11.10.2 LG Life Sciences Overview
11.10.3 LG Life Sciences Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 LG Life Sciences Pediatric Vaccines Products and Services
11.10.5 LG Life Sciences Pediatric Vaccines SWOT Analysis
11.10.6 LG Life Sciences Recent Developments
11.11 Lupin
11.11.1 Lupin Company Information
11.11.2 Lupin Overview
11.11.3 Lupin Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Lupin Pediatric Vaccines Products and Services
11.11.5 Lupin Recent Developments
11.12 S K Chemicals
11.12.1 S K Chemicals Company Information
11.12.2 S K Chemicals Overview
11.12.3 S K Chemicals Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 S K Chemicals Pediatric Vaccines Products and Services
11.12.5 S K Chemicals Recent Developments
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Company Information
11.13.2 Mitsubishi Tanabe Pharma Overview
11.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Products and Services
11.13.5 Mitsubishi Tanabe Pharma Recent Developments
11.14 Janssen
11.14.1 Janssen Company Information
11.14.2 Janssen Overview
11.14.3 Janssen Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Janssen Pediatric Vaccines Products and Services
11.14.5 Janssen Recent Developments
11.15 Shenzhen Kangtai Biological Products
11.15.1 Shenzhen Kangtai Biological Products Company Information
11.15.2 Shenzhen Kangtai Biological Products Overview
11.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Products and Services
11.15.5 Shenzhen Kangtai Biological Products Recent Developments
11.16 Sinovac Biotech
11.16.1 Sinovac Biotech Company Information
11.16.2 Sinovac Biotech Overview
11.16.3 Sinovac Biotech Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 Sinovac Biotech Pediatric Vaccines Products and Services
11.16.5 Sinovac Biotech Recent Developments
11.17 Bharat Biotech
11.17.1 Bharat Biotech Company Information
11.17.2 Bharat Biotech Overview
11.17.3 Bharat Biotech Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.17.4 Bharat Biotech Pediatric Vaccines Products and Services
11.17.5 Bharat Biotech Recent Developments
11.18 Crucell
11.18.1 Crucell Company Information
11.18.2 Crucell Overview
11.18.3 Crucell Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.18.4 Crucell Pediatric Vaccines Products and Services
11.18.5 Crucell Recent Developments
11.19 Dynavax
11.19.1 Dynavax Company Information
11.19.2 Dynavax Overview
11.19.3 Dynavax Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.19.4 Dynavax Pediatric Vaccines Products and Services
11.19.5 Dynavax Recent Developments
11.20 Serum Institute of India
11.20.1 Serum Institute of India Company Information
11.20.2 Serum Institute of India Overview
11.20.3 Serum Institute of India Pediatric Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.20.4 Serum Institute of India Pediatric Vaccines Products and Services
11.20.5 Serum Institute of India Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pediatric Vaccines Value Chain Analysis
12.2 Pediatric Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pediatric Vaccines Production Mode & Process
12.4 Pediatric Vaccines Sales and Marketing
12.4.1 Pediatric Vaccines Sales Channels
12.4.2 Pediatric Vaccines Distributors
12.5 Pediatric Vaccines Customers
13 Market Dynamics
13.1 Pediatric Vaccines Industry Trends
13.2 Pediatric Vaccines Market Drivers
13.3 Pediatric Vaccines Market Challenges
13.4 Pediatric Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pediatric Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Diphtheria
Table 3. Major Manufacturers of Influenza
Table 4. Major Manufacturers of Hepatitis
Table 5. Major Manufacturers of Pneumococcal Diseases
Table 6. Major Manufacturers of Meningococcal Diseases
Table 7. Major Manufacturers of Others
Table 8. Global Pediatric Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Pediatric Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Pediatric Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 11. Global Pediatric Vaccines Revenue Market Share by Region (2018-2024)
Table 12. Global Pediatric Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global Pediatric Vaccines Revenue Market Share by Region (2024-2034)
Table 14. Global Pediatric Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 15. Global Pediatric Vaccines Sales by Region (2018-2024) & (K Units)
Table 16. Global Pediatric Vaccines Sales Market Share by Region (2018-2024)
Table 17. Global Pediatric Vaccines Sales by Region (2024-2034) & (K Units)
Table 18. Global Pediatric Vaccines Sales Market Share by Region (2024-2034)
Table 19. Global Pediatric Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 20. Global Pediatric Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 21. Global Pediatric Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 22. Global Pediatric Vaccines Revenue Share by Manufacturers (2018-2024)
Table 23. Global Pediatric Vaccines Price by Manufacturers 2018-2024 (USD/Unit)
Table 24. Global Key Players of Pediatric Vaccines, Industry Ranking, 2021 VS 2022
Table 25. Global Pediatric Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Pediatric Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Vaccines as of 2022)
Table 27. Global Key Manufacturers of Pediatric Vaccines, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Pediatric Vaccines, Product Offered and Application
Table 29. Global Key Manufacturers of Pediatric Vaccines, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Pediatric Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 32. Global Pediatric Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 33. Global Pediatric Vaccines Sales Quantity Share by Type (2018-2024)
Table 34. Global Pediatric Vaccines Sales Quantity Share by Type (2024-2034)
Table 35. Global Pediatric Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 36. Global Pediatric Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 37. Global Pediatric Vaccines Revenue Share by Type (2018-2024)
Table 38. Global Pediatric Vaccines Revenue Share by Type (2024-2034)
Table 39. Pediatric Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 40. Global Pediatric Vaccines Price Forecast by Type (2024-2034) & (USD/Unit)
Table 41. Global Pediatric Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 42. Global Pediatric Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 43. Global Pediatric Vaccines Sales Quantity Share by Application (2018-2024)
Table 44. Global Pediatric Vaccines Sales Quantity Share by Application (2024-2034)
Table 45. Global Pediatric Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 46. Global Pediatric Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 47. Global Pediatric Vaccines Revenue Share by Application (2018-2024)
Table 48. Global Pediatric Vaccines Revenue Share by Application (2024-2034)
Table 49. Pediatric Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 50. Global Pediatric Vaccines Price Forecast by Application (2024-2034) & (USD/Unit)
Table 51. North America Pediatric Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 52. North America Pediatric Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 53. North America Pediatric Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 54. North America Pediatric Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 55. North America Pediatric Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 56. North America Pediatric Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 57. North America Pediatric Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 58. North America Pediatric Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 59. North America Pediatric Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 60. North America Pediatric Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 61. North America Pediatric Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 62. North America Pediatric Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 63. North America Pediatric Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 64. North America Pediatric Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 65. North America Pediatric Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 66. Europe Pediatric Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 67. Europe Pediatric Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 68. Europe Pediatric Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 69. Europe Pediatric Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 70. Europe Pediatric Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 71. Europe Pediatric Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 72. Europe Pediatric Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 73. Europe Pediatric Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 74. Europe Pediatric Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 75. Europe Pediatric Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 76. Europe Pediatric Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 77. Europe Pediatric Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 78. Europe Pediatric Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 79. Europe Pediatric Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 80. Europe Pediatric Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 81. China Pediatric Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 82. China Pediatric Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 83. China Pediatric Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 84. China Pediatric Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 85. China Pediatric Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 86. China Pediatric Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 87. China Pediatric Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 88. China Pediatric Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 89. China Pediatric Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 90. China Pediatric Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 91. APAC Pediatric Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 92. APAC Pediatric Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 93. APAC Pediatric Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 94. APAC Pediatric Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 95. APAC Pediatric Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 96. APAC Pediatric Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 97. APAC Pediatric Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 98. APAC Pediatric Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 99. APAC Pediatric Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 100. APAC Pediatric Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 101. APAC Pediatric Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 102. APAC Pediatric Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 103. APAC Pediatric Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 104. APAC Pediatric Vaccines Sales Quantity by Region (2018-2024) & (K Units)
Table 105. APAC Pediatric Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Pediatric Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Pediatric Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Pediatric Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 113. Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 114. Middle East, Africa and Latin America Pediatric Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Pediatric Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Pediatric Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 117. Middle East, Africa and Latin America Pediatric Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 118. Middle East, Africa and Latin America Pediatric Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 119. Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 120. Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 121. GlaxoSmithKline Company Information
Table 122. GlaxoSmithKline Description and Overview
Table 123. GlaxoSmithKline Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 124. GlaxoSmithKline Pediatric Vaccines Product and Services
Table 125. GlaxoSmithKline Pediatric Vaccines SWOT Analysis
Table 126. GlaxoSmithKline Recent Developments
Table 127. Merck Company Information
Table 128. Merck Description and Overview
Table 129. Merck Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 130. Merck Pediatric Vaccines Product and Services
Table 131. Merck Pediatric Vaccines SWOT Analysis
Table 132. Merck Recent Developments
Table 133. Pfizer Company Information
Table 134. Pfizer Description and Overview
Table 135. Pfizer Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 136. Pfizer Pediatric Vaccines Product and Services
Table 137. Pfizer Pediatric Vaccines SWOT Analysis
Table 138. Pfizer Recent Developments
Table 139. Sanofi Company Information
Table 140. Sanofi Description and Overview
Table 141. Sanofi Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 142. Sanofi Pediatric Vaccines Product and Services
Table 143. Sanofi Pediatric Vaccines SWOT Analysis
Table 144. Sanofi Recent Developments
Table 145. AstraZeneca Company Information
Table 146. AstraZeneca Description and Overview
Table 147. AstraZeneca Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 148. AstraZeneca Pediatric Vaccines Product and Services
Table 149. AstraZeneca Pediatric Vaccines SWOT Analysis
Table 150. AstraZeneca Recent Developments
Table 151. Novartis Company Information
Table 152. Novartis Description and Overview
Table 153. Novartis Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 154. Novartis Pediatric Vaccines Product and Services
Table 155. Novartis Pediatric Vaccines SWOT Analysis
Table 156. Novartis Recent Developments
Table 157. Takeda Pharmaceutical Company Information
Table 158. Takeda Pharmaceutical Description and Overview
Table 159. Takeda Pharmaceutical Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 160. Takeda Pharmaceutical Pediatric Vaccines Product and Services
Table 161. Takeda Pharmaceutical Pediatric Vaccines SWOT Analysis
Table 162. Takeda Pharmaceutical Recent Developments
Table 163. Bavarian Nordic Company Information
Table 164. Bavarian Nordic Description and Overview
Table 165. Bavarian Nordic Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 166. Bavarian Nordic Pediatric Vaccines Product and Services
Table 167. Bavarian Nordic Pediatric Vaccines SWOT Analysis
Table 168. Bavarian Nordic Recent Developments
Table 169. Baxter Company Information
Table 170. Baxter Description and Overview
Table 171. Baxter Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 172. Baxter Pediatric Vaccines Product and Services
Table 173. Baxter Pediatric Vaccines SWOT Analysis
Table 174. Baxter Recent Developments
Table 175. LG Life Sciences Company Information
Table 176. LG Life Sciences Description and Overview
Table 177. LG Life Sciences Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 178. LG Life Sciences Pediatric Vaccines Product and Services
Table 179. LG Life Sciences Pediatric Vaccines SWOT Analysis
Table 180. LG Life Sciences Recent Developments
Table 181. Lupin Company Information
Table 182. Lupin Description and Overview
Table 183. Lupin Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 184. Lupin Pediatric Vaccines Product and Services
Table 185. Lupin Recent Developments
Table 186. S K Chemicals Company Information
Table 187. S K Chemicals Description and Overview
Table 188. S K Chemicals Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 189. S K Chemicals Pediatric Vaccines Product and Services
Table 190. S K Chemicals Recent Developments
Table 191. Mitsubishi Tanabe Pharma Company Information
Table 192. Mitsubishi Tanabe Pharma Description and Overview
Table 193. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 194. Mitsubishi Tanabe Pharma Pediatric Vaccines Product and Services
Table 195. Mitsubishi Tanabe Pharma Recent Developments
Table 196. Janssen Company Information
Table 197. Janssen Description and Overview
Table 198. Janssen Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 199. Janssen Pediatric Vaccines Product and Services
Table 200. Janssen Recent Developments
Table 201. Shenzhen Kangtai Biological Products Company Information
Table 202. Shenzhen Kangtai Biological Products Description and Overview
Table 203. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 204. Shenzhen Kangtai Biological Products Pediatric Vaccines Product and Services
Table 205. Shenzhen Kangtai Biological Products Recent Developments
Table 206. Sinovac Biotech Company Information
Table 207. Sinovac Biotech Description and Overview
Table 208. Sinovac Biotech Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 209. Sinovac Biotech Pediatric Vaccines Product and Services
Table 210. Sinovac Biotech Recent Developments
Table 211. Bharat Biotech Company Information
Table 212. Bharat Biotech Description and Overview
Table 213. Bharat Biotech Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 214. Bharat Biotech Pediatric Vaccines Product and Services
Table 215. Bharat Biotech Recent Developments
Table 216. Crucell Company Information
Table 217. Crucell Description and Overview
Table 218. Crucell Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 219. Crucell Pediatric Vaccines Product and Services
Table 220. Crucell Recent Developments
Table 221. Dynavax Company Information
Table 222. Dynavax Description and Overview
Table 223. Dynavax Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 224. Dynavax Pediatric Vaccines Product and Services
Table 225. Dynavax Recent Developments
Table 226. Serum Institute of India Company Information
Table 227. Serum Institute of India Description and Overview
Table 228. Serum Institute of India Pediatric Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 229. Serum Institute of India Pediatric Vaccines Product and Services
Table 230. Serum Institute of India Recent Developments
Table 231. Key Raw Materials Lists
Table 232. Raw Materials Key Suppliers Lists
Table 233. Pediatric Vaccines Distributors List
Table 234. Pediatric Vaccines Customers List
Table 235. Pediatric Vaccines Market Trends
Table 236. Pediatric Vaccines Market Drivers
Table 237. Pediatric Vaccines Market Challenges
Table 238. Pediatric Vaccines Market Restraints
Table 239. Research Programs/Design for This Report
Table 240. Key Data Information from Secondary Sources
Table 241. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Vaccines Product Picture
Figure 2. Global Pediatric Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pediatric Vaccines Market Share by Type in 2022 & 2034
Figure 4. Diphtheria Product Picture
Figure 5. Influenza Product Picture
Figure 6. Hepatitis Product Picture
Figure 7. Pneumococcal Diseases Product Picture
Figure 8. Meningococcal Diseases Product Picture
Figure 9. Others Product Picture
Figure 10. Global Pediatric Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 11. Global Pediatric Vaccines Market Share by Application in 2022 & 2034
Figure 12. Newborn
Figure 13. Infant
Figure 14. Child
Figure 15. Dolescent
Figure 16. Pediatric Vaccines Report Years Considered
Figure 17. Global Pediatric Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global Pediatric Vaccines Revenue 2018-2034 (US$ Million)
Figure 19. Global Pediatric Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 20. Global Pediatric Vaccines Sales Quantity 2018-2034 (K Units)
Figure 21. Global Pediatric Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 22. Global Pediatric Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 23. North America Pediatric Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. North America Pediatric Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Europe Pediatric Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. Europe Pediatric Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. China Pediatric Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. China Pediatric Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 29. APAC Pediatric Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 30. APAC Pediatric Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 32. Middle East, Africa and Latin America Pediatric Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Pediatric Vaccines Sales Quantity in 2022
Figure 34. The Top 10 and Top 5 Players Market Share by Pediatric Vaccines Revenue in 2022
Figure 35. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Pediatric Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 37. Global Pediatric Vaccines Revenue Market Share by Type (2018-2034)
Figure 38. Global Pediatric Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 39. Global Pediatric Vaccines Revenue Market Share by Application (2018-2034)
Figure 40. North America Pediatric Vaccines Revenue Market Share by Company in 2022
Figure 41. North America Pediatric Vaccines Sales Quantity Market Share by Company in 2022
Figure 42. North America Pediatric Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 43. North America Pediatric Vaccines Revenue Market Share by Type (2018-2034)
Figure 44. North America Pediatric Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 45. North America Pediatric Vaccines Revenue Market Share by Application (2018-2034)
Figure 46. North America Pediatric Vaccines Revenue Share by Country (2018-2034)
Figure 47. North America Pediatric Vaccines Sales Quantity Share by Country (2018-2034)
Figure 48. U.S. Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 49. Canada Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 50. Europe Pediatric Vaccines Sales Quantity Market Share by Company in 2022
Figure 51. Europe Pediatric Vaccines Revenue Market Share by Company in 2022
Figure 52. Europe Pediatric Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 53. Europe Pediatric Vaccines Revenue Market Share by Type (2018-2034)
Figure 54. Europe Pediatric Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 55. Europe Pediatric Vaccines Revenue Market Share by Application (2018-2034)
Figure 56. Europe Pediatric Vaccines Revenue Share by Country (2018-2034)
Figure 57. Europe Pediatric Vaccines Sales Quantity Share by Country (2018-2034)
Figure 58. Germany Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 59. France Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 60. U.K. Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 61. Italy Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 62. Russia Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 63. China Pediatric Vaccines Sales Quantity Market Share by Company in 2022
Figure 64. China Pediatric Vaccines Revenue Market Share by Company in 2022
Figure 65. China Pediatric Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 66. China Pediatric Vaccines Revenue Market Share by Type (2018-2034)
Figure 67. China Pediatric Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 68. China Pediatric Vaccines Revenue Market Share by Application (2018-2034)
Figure 69. APAC Pediatric Vaccines Sales Quantity Market Share by Company in 2022
Figure 70. APAC Pediatric Vaccines Revenue Market Share by Company in 2022
Figure 71. APAC Pediatric Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 72. APAC Pediatric Vaccines Revenue Market Share by Type (2018-2034)
Figure 73. APAC Pediatric Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 74. APAC Pediatric Vaccines Revenue Market Share by Application (2018-2034)
Figure 75. APAC Pediatric Vaccines Revenue Share by Region (2018-2034)
Figure 76. APAC Pediatric Vaccines Sales Quantity Share by Region (2018-2034)
Figure 77. Japan Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 78. South Korea Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 79. China Taiwan Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 80. Southeast Asia Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 81. India Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 82. Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity Market Share by Company in 2022
Figure 83. Middle East, Africa and Latin America Pediatric Vaccines Revenue Market Share by Company in 2022
Figure 84. Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Pediatric Vaccines Revenue Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Pediatric Vaccines Revenue Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Pediatric Vaccines Sales Quantity Share by Country (2018-2034)
Figure 89. Middle East, Africa and Latin America Pediatric Vaccines Revenue Share by Country (2018-2034)
Figure 90. Brazil Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 91. Mexico Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 92. Turkey Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 93. Israel Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 94. GCC Countries Pediatric Vaccines Revenue (2018-2034) & (US$ Million)
Figure 95. Pediatric Vaccines Value Chain
Figure 96. Pediatric Vaccines Production Process
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed